Hims & Hers Health, Inc. faces a proposed securities class action following a July 29, 2026 lawsuit by the Federal Trade Commission, California and Utah that alleged consumer-protection violations. Wolf Haldenstein Adler Freeman & Herz LLP said the investor complaint covers purchasers of Hims & Hers securities between August 4, 22025, and July 29, 2026, and alleges the company made misleading statements and omitted material information about prescription charges, subscription cancellations and consumer-health-data privacy. The complaint alleges that Hims & Hers shared health information with Meta, Snap and other third parties, and that the alleged conduct exposed the company to regulatory scrutiny, fees and penalties. Hims & Hers shares fell $4.32, or 14.73%, to close at $25.00 on July 29. Investors seeking appointment as lead plaintiff must do so by November 2, 2026.